124 related articles for article (PubMed ID: 24565830)
1. Cellular sources of tenascin-C in canine mammary carcinomas.
Yoshimura H; Michishita M; Ohkusu-Tsukada K; Matsuda Y; Ishiwata T; Naito Z; Takahashi K
Vet Pathol; 2015 Jan; 52(1):92-6. PubMed ID: 24565830
[TBL] [Abstract][Full Text] [Related]
2. Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors.
Yoshimura H; Michishita M; Ohkusu-Tsukada K; Takahashi K
Vet Pathol; 2011 Jan; 48(1):313-21. PubMed ID: 20571146
[TBL] [Abstract][Full Text] [Related]
3. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
4. Appearance and distribution of stromal myofibroblasts and tenascin-C in feline mammary tumors.
Yoshimura H; Michishita M; Ohkusu-Tsukada K; Takahashi K
Histol Histopathol; 2011 Mar; 26(3):297-305. PubMed ID: 21210342
[TBL] [Abstract][Full Text] [Related]
5. Myoepithelial cell layer integrity in canine mammary carcinoma.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
[TBL] [Abstract][Full Text] [Related]
6. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
7. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
8. Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors.
Tateyama S; Uchida K; Hidaka T; Hirao M; Yamaguchi R
Vet Pathol; 2001 Nov; 38(6):703-9. PubMed ID: 11732805
[TBL] [Abstract][Full Text] [Related]
9. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.
Hindermann W; Berndt A; Borsi L; Luo X; Hyckel P; Katenkamp D; Kosmehl H
J Pathol; 1999 Dec; 189(4):475-80. PubMed ID: 10629546
[TBL] [Abstract][Full Text] [Related]
11. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
[TBL] [Abstract][Full Text] [Related]
12. Versican expression in myoepithelial cells from carcinomas in canine mixed mammary tumors.
Damasceno KA; Bertagnolli AC; Estrela-Lima A; Rabelo BS; Campos LC; Ribeiro LG; Cassali GD
Vet J; 2014 Apr; 200(1):146-51. PubMed ID: 24582132
[TBL] [Abstract][Full Text] [Related]
13. Differences in indicators of malignancy between luminal epithelial cell type and myoepithelial cell type of simple solid carcinoma in the canine mammary gland.
Yoshimura H; Nakahira R; Kishimoto TE; Michishita M; Ohkusu-Tsukada K; Takahashi K
Vet Pathol; 2014 Nov; 51(6):1090-5. PubMed ID: 24448671
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours.
Łopuszyński W; Szczubiał M; Millán Y; Guil-Luna S; Sánchez-Céspedes R; Martin de Las Mulas J; Śmiech A; Bulak K
Res Vet Sci; 2019 Apr; 123():232-238. PubMed ID: 30685648
[TBL] [Abstract][Full Text] [Related]
15. Isolation, purification, culture and characterisation of myoepithelial cells from normal and neoplastic canine mammary glands using a magnetic-activated cell sorting separation system.
Sánchez-Céspedes R; Maniscalco L; Iussich S; Martignani E; Guil-Luna S; De Maria R; Martín de Las Mulas J; Millán Y
Vet J; 2013 Aug; 197(2):474-82. PubMed ID: 23583698
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
18. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of chondromodulin-I (ChM-I) and bone morphogenetic protein-6 (BMP-6) in myoepithelial cells of canine mammary tumors.
Kawabata A; Okano K; Uchida K; Yamaguchi R; Hayashi T; Tateyama S
J Vet Med Sci; 2005 Nov; 67(11):1097-102. PubMed ID: 16327219
[TBL] [Abstract][Full Text] [Related]
20. Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors.
Arai K; Nakano H; Shibutani M; Naoi M; Matsuda H
Vet Pathol; 2003 Nov; 40(6):670-6. PubMed ID: 14608020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
